picFloatLeft
Raise money for charity with everyclick search
Search

the Optimist view

If you are an optimist – or aspire to be one - welcome to our world. Here at Optimist World you'll find daily good news headlines, inspiring stories about charities, positive corporate social responsibility activities, sustainable travel, optimistic stories from the world of sports, and so much more

Good News as scientists offer new hope for AIDS vaccine from artifical antibodies

By Simon Meadows

Last updated 5/20/2009 5:50:29 PM

Good News as scientists offer new hope for AIDS vaccine from artifical antibodies

Researchers may have discovered a technique that will eventually lead to a way to vaccinate against the AIDS virus, by creating an artificial antibody carried into the body by a virus, Reuters reports.

This synthetic immune system molecule protected monkeys against an animal version of HIV called SIV. While it will be years before the concept could be tested in humans, it opens up the possibility of protecting people against the fatal and incurable virus.

"Six of nine immunized monkeys were protected against infection by the SIV challenge, and all nine were protected from AIDS," Philip Johnson of Children's Hospital of Philadelphia and colleagues wrote.

Several attempts to create a vaccine against the human immunodeficiency virus that causes AIDS have failed. AIDS not only attacks the immune cells that usually defend against viruses, but it quickly hides out in an as-yet undiscovered "reservoir" so the immune system must be primed to capture virtually every single virus.

In addition, people do not usually make antibodies against the virus. Antibodies are immune system particles that latch on to invaders so killer cells can destroy them.

Johnson's team engineered an artificial piece of DNA that would make artificial antibodies, called antibody-like proteins or immunoadhesins.

"As a concept, I think this is very promising," Dr. Peggy Johnston, head of the HIV Vaccine Research Branch at the National Institute of Allergy and Infectious Diseases, which helped pay for the study.

Source: www.reuters.com




Post this story to:

Your comments:
Please type your comment here and click the button to submit.
Advertisement
100percent_recycled_negativity
Powered by Alpine Interactive